Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.
about
Everolimus-eluting stents in interventional cardiologyLong-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysisEverolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomesDuration of dual antiplatelet treatment in the era of next generation drug-eluting stentsFirst-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patientsMacromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary interventionAdvances in stent technologies and their effect on clinical efficacy and safetyThree-year data from the XIENCE V INDIA study: safety and efficacy of XIENCE V in 1000 real world Indian patients.Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program.A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: design and statistical methods of the PERSEUS clinical programCritical evaluation of stents in the peripheral arterial disease of the superficial femoral artery - focus on the paclitaxel eluting stentDrug-eluting stentsA randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with CoronarEffects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysisClinical impact of routine follow-up coronary angiography after second- or third-generation drug-eluting stent insertion in clinically stable patientsSelective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports.Comparison of optical coherence tomographic assessment between first- and second-generation drug-eluting stentsComparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries.Treatment of intracranial atherosclerotic disease with a balloon-expandable paclitaxel eluting stent: procedural safety, efficacy and mid-term patency.Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cellsComparison of First- and Second-Generation Drug-Eluting Stents in an All-Comer Population of Patients with Diabetes Mellitus (from Katowice-Zabrze Registry).Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysisA novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease.Blood compatibility assessment of polymers used in drug eluting stent coatings.Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.A prospective, randomized comparison of promus everolimus-eluting and TAXUS Liberte paclitaxel-eluting stent systems in patients with coronary artery disease eligible for percutaneous coronary intervention: the PROMISE study.Angiographic and clinical comparison of novel Orsiro Hybrid sirolimus-eluting stents and Resolute Integrity zotarolimus-eluting stents in all-comers with coronary artery disease (ORIENT trial): study protocol for a randomized controlled trialA review of current devices and a look at new technology: drug-eluting stents.A first-in-man study of sirolimus-eluting, biodegradable polymer coated cobalt chromium stent in real life patients.Acute coronary syndromes: Diagnosis and management, part II.A critical appraisal of the safety and efficacy of drug-eluting stents.Drug-eluting stents: a comprehensive appraisal.Xience V everolimus-eluting coronary stent.Genous endothelial progenitor cell-capturing stent system: a novel stent technology.Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.Factors that affect mass transport from drug eluting stents into the artery wall.Current status of drug-eluting stents.Decision-making: stenting in acute myocardial infarction.Pharmacological prevention and management of restenosis.Local drug delivery for treatment of coronary and peripheral artery disease.
P2860
Q24630321-0E5815FC-FA30-43FD-91CB-A2A01F62AD5EQ26767320-5EBD7C12-B5FD-46C2-A3BC-29B88D976241Q26798582-F1DF7218-5A4A-4118-BF34-014B1B979A24Q26830266-35EA8402-353E-4D36-86EB-964C7A18B4F4Q28543594-B553F94B-F201-4AEA-A266-350CD180D839Q28654633-C3A76959-AE25-45AA-8639-A86CB07CB32DQ28972437-36240319-CDDD-4EF7-866B-E92C40F2615BQ30833808-887F5E61-2731-4C2B-8AFC-2DC05551A4A3Q33571243-2756AA6C-7AE9-40CA-823A-34EF5B93B655Q33677854-99211AFB-15BF-433C-B4AA-F5251139D4DFQ33710114-EA1D2E11-3E75-431B-9DA3-F54FCB248AF4Q34091036-88ABD59A-DA2F-4FFD-B5C9-52F010F8089EQ34354151-86359E14-E692-44FB-99CF-56EBB891A437Q34452943-6739172C-AB5B-4F51-88A4-9B76ED85A807Q34948151-CDCE7A56-CEF4-4D2F-8088-AA33745ABAF3Q35716074-A9673A65-732D-46BA-9A27-5FEF2A9FAE1EQ35932110-B9584C05-6518-457F-848A-CC1229B0D6A1Q36146253-1BD29C27-9C0F-4780-9C1D-4E610A95CA4FQ36203503-1C507F77-5120-4632-BB54-5D04CF07DB19Q36206234-704D3D79-9D28-460D-8E54-8732B203796BQ36239147-A970CAE4-B10C-421A-B97A-3E5410E41E89Q36856022-52BBE845-BE9C-42B1-A605-D5ED556166F2Q36954581-90158822-0286-4794-B54E-8B3BB883D3DCQ37238906-89587FAC-4994-4C01-9709-FFBF75790226Q37284036-F29DA1E9-AFAE-4738-A2FE-23D6E2B1DCCCQ37329589-23A3DF84-7CC3-44A3-88CB-51DB43E6C0BCQ37347986-F5065B12-E002-44C1-A653-3647D3CD892EQ37357342-D7FAE3E4-EDC9-4881-A7FC-09E07FEA9645Q37388152-CE90F321-D63D-4D20-91F5-1DD9D49D64CAQ37406719-E2F37759-E554-4458-BA5B-04B0D5550E69Q37412922-8E34A66F-8C08-43C9-9846-8E209BDFAB3BQ37445860-428B9DF9-C3D0-48BA-9E4C-B1B6A757FBE1Q37472070-DCC054F1-3789-4C8B-9AF2-48CAE2E369FCQ37538723-7A512F95-9E75-4556-9B39-9488C50D66BCQ37685137-D2CFC4A3-33F4-467E-9165-3C4901C653C6Q37705587-1812D730-963E-42E5-B8B4-E09CBE158E87Q37725108-3ECD2027-903E-4E7C-A6F1-9AD05BA593CBQ37749818-FECAEA58-3BEC-4CF7-951A-03D7A54503A3Q37756979-5C4CA86A-67A3-4147-88AD-C9D56C4739E4Q37765610-534FC856-8586-49DF-892E-299EAACC5334
P2860
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Comparison of an everolimus-el ...... y disease: a randomized trial.
@en
type
label
Comparison of an everolimus-el ...... y disease: a randomized trial.
@en
prefLabel
Comparison of an everolimus-el ...... y disease: a randomized trial.
@en
P2093
P356
P1476
Comparison of an everolimus-el ...... y disease: a randomized trial.
@en
P2093
Alexandra J Lansky
Donald E Cutlip
Gregg W Stone
James B Hermiller
Jerome Williams
Mark Midei
Naim Farhat
Peter J Fitzgerald
Poornima Sood
P304
P356
10.1001/JAMA.299.16.1903
P407
P577
2008-04-01T00:00:00Z